As of 2025-07-06, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (26.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.03 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -305.7%.
The range of the Relative Valuation is (25.30) - (25.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 18.6x | 18.3x |
| Forward P/E multiples | 18.2x - 20.9x | 20.3x |
| Fair Price | (25.30) - (25.86) | (26.80) |
| Upside | -294.2% - -298.4% | -305.7% |
| Date | P/E |
| 2025-07-03 | -9.38 |
| 2025-07-02 | -9.37 |
| 2025-07-01 | -9.23 |
| 2025-06-30 | -9.44 |
| 2025-06-27 | -9.48 |
| 2025-06-26 | -9.40 |
| 2025-06-25 | -10.32 |
| 2025-06-24 | -10.62 |
| 2025-06-23 | -10.21 |
| 2025-06-20 | -10.30 |
| 2025-06-18 | -10.42 |
| 2025-06-17 | -10.43 |
| 2025-06-16 | -10.57 |
| 2025-06-13 | -11.01 |
| 2025-06-12 | -11.10 |
| 2025-06-11 | -11.34 |
| 2025-06-10 | -11.13 |
| 2025-06-09 | -10.99 |
| 2025-06-06 | -10.97 |
| 2025-06-05 | -10.67 |
| 2025-06-04 | -10.43 |
| 2025-06-03 | -10.69 |
| 2025-06-02 | -10.58 |
| 2025-05-30 | -10.28 |
| 2025-05-29 | -10.49 |
| 2025-05-28 | -10.07 |
| 2025-05-27 | -10.32 |
| 2025-05-23 | -10.23 |
| 2025-05-22 | -10.10 |
| 2025-05-21 | -10.51 |
| 2025-05-20 | -10.71 |
| 2025-05-19 | -10.65 |
| 2025-05-16 | -10.64 |
| 2025-05-15 | -10.41 |
| 2025-05-14 | -10.48 |
| 2025-05-13 | -10.72 |
| 2025-05-12 | -10.67 |
| 2025-05-09 | -10.50 |
| 2025-05-08 | -10.59 |
| 2025-05-07 | -10.46 |
| 2025-05-06 | -10.36 |
| 2025-05-05 | -11.91 |
| 2025-05-02 | -12.18 |
| 2025-05-01 | -12.01 |
| 2025-04-30 | -11.81 |
| 2025-04-29 | -11.13 |
| 2025-04-28 | -11.29 |
| 2025-04-25 | -10.69 |
| 2025-04-24 | -11.09 |
| 2025-04-23 | -10.68 |